Module 1 Flashcards

1
Q

Pharmacokinetics

A

movement of drug through body (what body does to the drug)

absorption, distribution, metabolism, excretion

MEC, steady state, duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pharmacodynamics

A

study of the effects of the drug (what drug does to the body)

receptor binding, post receptor effects, chemical reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Minimum Effective Concentration (MEC)

A

the minimum amount of drug required to work (to produce intended effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Absorption

A

movement of drug into the bloodstream

• passive transport (diffusion, facilitated diffusion)
• active transport (requires energy and enzyme)
• pinocytosis (cell carries drug across membrane by engulfing drug particles)

factors affecting absorption are blood circulation, pain, stress, food texture/fat content/temp, pH, route of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

First Pass Effect (Absorption)

A

how much of the drug is metabolized in liver after passing through GI tract via hepatic vein

ingestion, absorption into small intestine, portal circulation through portal vein to liver, metabolism, reduced bioavailability with PO MEDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bioavailability

A

percentage of drug in the bloodstream after first pass effect

IV push= 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Distribution

A

distribution of the drug into the tissues

the drug is exiting the vascular system and being deposited to the tissues

consider transfer through capillary beds, placenta, blood brain barrier (BBB) aka permeability of cell membrane and circulation, etc.

protein binding (albumin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Metabolism (Biotransformation)

A

how the body chemically modifies drugs into what can be excreted (P40 liver system)

consider liver function because it’s the main metabolism organ; liver lab values as well as age (infants and elderly)

therapeutic consequences: accelerated renal drug exertion, increased therapeutic action, activation of prodrugs, increased/decreased toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Excretion

A

removal of the drug from the body (GI, kidneys, lungs, breast milk, saliva, hair, sweat, bile)

consider kidney function because it’s the main excretion organ; GFR, creatinine, BUN

first pass loss, half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Half-Life

A

the time it takes for half the drug to be eliminated

if a drug has a short half life, that means it leaves the body quickly/higher risk of dependency and lower risk for toxicity…long half life means it leaves the body slowly/lower risk for dependency and higher risk for toxicity…CONSIDER DOSING

single dose time course determined by metabolism and excretion, repeated doses to achieve plateau drug lvls (takes time to plateau); LOADING DOSE VS MAINTENANCE DOSE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Therapeutic Index (TI)

A

a way to monitor the concentration of certain drugs is through obtaining a peak (highest concentration of drug in blood; most active) and a trough (lowest concentration of drug in blood; usually measured before next dose) level (”titers”, “serum drug levels”)

RATIO BETWEEN MTC AND MEC

some drugs have a narrow TI and need close monitoring of these lvls, high TI means drug is safer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Onset

A

when drug starts to have effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Peak

A

what time is highest concentration of drug in bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Duration

A

how long drug effects lasts (therapeutic effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Receptor Theory

A

the proteins bind to receptors and tell the cells to activate or inactivate to produce or block a response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Agonist

A

turns on receptors

partial agonist lower affect than full agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Antagonist

A

blocks receptors

non-receptor responses: no use receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Non-Specific

A

one type of receptor at multiple sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Non-Selective

A

multiple types of receptors anywhere in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pharmacogenetics

A

the study of genetic factors influencing individual drug response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Focus of Pharmacogenetic Testing

A

look at specific DNA segments that play a role in the body’s response to a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Benefits of Pharmacogenetic Testing

A
  1. individualized treatment regimen
  2. decreases drug reactions and treatment failures
  3. promotes drug adherence
  4. reduces healthcare costs
  5. improve quality outcomes
  6. predict pt response to drug therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Interpatient Variability in Drug Responses (Pharmacodynamics)

A

measurement of inpatient variability; the ED50 vs LD50 (TI is ratio between these and can overlap between the curve for what is effective and what is lethal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Additive

A

sum of effects of 2 drugs; increased effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Synergistic

A

effect is much greater than effects of either drug alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Antagonistic

A

one drug reduces/blocks effect of other drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Drug-Nutrient Interactions

A

food may increase, decrease or delay drug response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Drug-Lab Interactions

A

drugs may cause misinterpretations of test results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Drug-induced photosensitivity

A

skin reaction caused by sunlight exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Pharmacogenomics

A

study of combo of pharmacology and genomics to develop effective and safe meds to compensate for genetic differences in pts that cause varied responses to a single therapeutic regimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Who benefits from pharmacogenetics?

A

those taking multiple prescription drugs
those not responding to current therapy
those having adverse drug reactions
those taking black box warning drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Toxicity

A

identified by monitoring the plasma (serum) therapeutic range of the drug

drug level exceeds TI- toxic effects are likely to occur from overdosing or drug accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Pregnant Clients

A

• MUST REPORT ALL MEDS TAKEN BECAUSE THEY ALL HAVE POTENTIAL RISK! (begin as early as 2 weeks after conception)
HEALTH OF FETUS RELIES ON HEALTH OF MOTHER SO MEDS MAY BE NECESSARY; PT EDUCATION!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

ABCDX Categories

A

A= smallest risk

B= slight risk

X= WORST RISK; TERATOGENIC EFFECT CONFIRMED; DO NOT USE: BACK UP BIRTH CONTROL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Pediatric Clients

A

• family centered care and should include safe med administration and pt teaching
• atraumatic care
• cognitive/affective/psychomotor skills

USE SMALLEST SYRINGE SIZE TO INCREASE ACCURACY OF DOSE GIVEN

MAINTAINING SAFETY WITH MINIMAL RESTRAINT; DISTRACTION AND OTHER NONPHARM FOR PAIN AND ANXIETY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Pediatric Dosing

A

different due to immature hepatic and renal function; meds are WEIGHT BASED

USE SMALLEST SYRINGE SIZE TO INCREASE ACCURACY OF DOSE GIVEN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Atraumatic Care

A

means to decrease psychological/physical distress; do NOT separate pediatric pts from caregivers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Older Adult Clients

A

• goal is to PROMOTE AUTONOMY, keep them independent
• polypharmacy
• expect that older adults CAN learn
• may need help with adherence (write down when meds are taken, use an app, etc.)
• determine if sensory/cognitive barriers exist
• toxicity and overdose may present as CONFUSION
• may see alterations in dosing due to aging organs/chronic illnesses; ESPECIALLY IN PTS WITH GI, KIDNEY, LIVER, OR CARDIAC

MONITOR FOR KIDNEY (BUN/CREATININE) AND LIVER (AST/ALT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Polypharmacy

A

5+ meds; increases risk for drug interactions and side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Basic Considerations of Drug Therapy During Pregnancy

A

health of fetus depends on health of mother

physiological changes during pregnancy

placental drug transfer

adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Drug Therapy During Breast Feeding

A

dose immediately after

avoid drugs that have a long half life

choose drugs that tend to be excluded from milk

choose drugs least likely to affect infant

avoid drugs that are known to be hazardous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Absorption Influencing Factors for Pediatrics

A

child’s age, health status, weight, route of administration

nutritional habits, physical maturity, hormonal differences

hydration, underlying disease, GI disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Route of Administration for Pediatrics

A

gastric acidity
emptying
motility
surface area
enzyme levels
intestinal flora

IM/SQ: peripheral effusion, effectiveness of circulation

Topical: children’s skin is thin and porous

44
Q

Distribution Influencing Factors for Pediatrics

A

body fluid composition (75% water)

body tissue composition (less body fat)

protein-binding capability (less albumin and fewer protein receptor sites)

effectiveness of barriers (skin, BBB)

45
Q

Metabolism Influencing Factors for Pediatrics

A

maturational lvl of child
liver metabolism
reduced hepatic blood flow and drug metabolizing enzymes
higher metabolic rate

46
Q

Excretion Influencing Factors for Pediatrics

A

kidneys (infants have decreased renal blood flow, GFR, renal tubular function)

intestines, salivary glands

lungs

sweat glands, mammary glands

47
Q

Adolescent Considerations

A

specific to developmental stage

physical changes
cognitive lvl and abilities
emotional factors
impact of chronic illness
self care abilities
social reasoning and decision making

48
Q

Family Centered Assessment

A

age, weight, height
developmental age
health status
history of drug use
nutritional/hydration status
cognitive level
family/child understanding

49
Q

Family Centered Planning

A

child and caregivers will…

recognize need for drug administration
incorporate drug treatment regimen into lifestyle
demonstrate safe drug administration practices

child receives dose based on assessment data consistent with guidelines

50
Q

Family Centered Interventions

A

• assist pt, family and caregivers to use appropriate follow up resources and support
• follow all rights of safe drug administration
• help pt, family and caregivers to manage complex drug schedules
• use educational strategies that are interactive and engaging for pediatric pt
• pt teaching

51
Q

Family Centered Patient Teaching

A

report use of OTC products
report side effects immediately
advise breastfeeding pt that a portion of most drugs is excreted in breast milk
keep meds out of reach for children
use child resistant containers

52
Q

Family Centered Evaluation

A

• determine family members knowledge concerning drug, dose, schedule for administration, and side effects
• determine child’s physiologic and psychological response
• determine therapeutic and adverse effects of drugs
• help pt, family and caregivers to manage complex drug schedules
• use educational strategies that are interactive and engaging for pediatric pt

53
Q

Older Adult Absorption

A

delayed gastric emptying; decreased gastric acidity and decreased splanchic blood flow

54
Q

Older Adult Distribution

A

higher % of fat; decreased lean muscles, total body water and plasma albumin concentration

55
Q

Older Adult Metabolism

A

decreased rate of liver metabolism of drugs and activity of liver enzymes

can raise half lives of some meds

56
Q

Older Adult Excretion

A

reduced renal excretion (decreased GFR and # of nephrons)

creatinine clearance more accurate than serum creatinine

57
Q

Geriatric Pharmocodynamics

A

• age related changes in CNS and cardiovascular system
• changes in # of drug receptors
• changes in affinity of receptors to drugs
• compensatory response to physiologic changes is decreased
• decreased responsiveness and sensitivity to baroreceptors
• changes in vision, hearing, endurance/mobility and skin

58
Q

Physiological Changes Associated with Diseases in Older Adults

A

cardiac (impaired CO, greater susceptibility to cardiac adverse effects)

kidney and liver disease

neurological (impaired cerebral blood flow, greater sensitivity to neurological effects of meds, diminished neurotransmitter lvls)

59
Q

Geriatric ADEs

A

stimulate stereotypes of growing old

falls from orthostatic hypotension
confusion and disorientation
nervousness
incontinence
malaise

60
Q

Medications Contributing to ADEs in Older Adults

A

cardiovascular
psychotropic meds
anti diabetic agents
antibiotics
anticoagulants
NSAIDs

61
Q

Older Adult Drug Adherence

A

pt may not fully understand drug regimen

nonadherence can cause under/overdosing

barriers to effective drug use; MED EDUCATION IS IMPORTANT!!

62
Q

Health Teaching: Special Considerations

A

• have pts senses be sharp (clean eyeglasses, functional hearing aids in place)
• speak in tones pt can hear
• face pt when speaking
• treat pt with respect; EXCEPT PT CAN LEARN
• use large print and bright colors when teaching
• review all meds at each visit
• encourages simple dosing schedule
• w/onset of confusion/disorientation, suspect recent prescribed meds
• encourage pt to report if new drug isn’t improving condition for which it was prescribed for

63
Q

PNS (Urinary Retention and HTN)

A

mediates detrusor muscle contraction; blocked by anticholinergic meds like diphenhydramine

64
Q

SNS (Urinary Retention and HTN)

A

alpha adrenergic activity causes urethral sphincter to contract (retaining urine)

alpha adrenergic activity increases systemic vascular resistance (raises BP)

decongestants are alpha adrenergic agonists (pseudoephedrine and phenylephrine)

65
Q

Orthostatic Hypotension and Hip Fracture

A

alpha adrenergic blockage can worsen postural hypotension and increase risk of falls

falls and hip fractures are associated with significant morbidity and mortality in older adults

66
Q

Drug Induced Delirium

A

meperidine- synthetic opioid (can cause confusion, activate metabolites and slow renal clearance in older adults)

diazepam- long acting benzodiazepine (extended half life in elderly, increased sensitivity in elderly and risk of falls/fractures)

67
Q

Beers Criteria

A

consensus based list of potentially inappropriate meds for older adults

68
Q

Antihistamines (Upper Respiratory)

H1 Receptor Antagonists

A

1st gen (diphenhydramine-Benadryl)

2nd gen (cetirizine- Zyrtec)

ANYTHING THAT ENDS IN -INE!!!

compete with histamine for receptor sites and prevent histamine response; relieves allergic reactions

consider safety with CNS depressants; consider age when administering, as older adults may be more sensitive to SE and children may have paradoxical effects

69
Q

Antihistamines SE

A

DROWSINESS (1st gen more severe)

dry mouth
urinary retention ANTICHOLINERGIC
constipation
blurred vision
excitation (paradoxical effect in children)

CANT SEE CANT PEE CANT SPIT CANT SHIT

monitor dosing in older adults d/t impairment of organs; more sensitive to SE

70
Q

Decongestants/Alpha Adrenergic Agonist (Upper Respiratory)

oxymetazoline (Afrin)

A

reduce swelling within blood vessels of nasal cavity and decreases secretion; stimulate SNS producing vascular constriction of capillaries within nasal mucosa which shrinks membranes and reduced fluid secretion

relives nasal/sinus congestion and decreases sinus pressure and decrease pain

sprays and drops preferred; oral form will cause systemic side effects
meds such as ephedrine, phenylephrine, pseudoephedrine (Alpha Adrenergic Agonists) may also be used for decongestant properties

71
Q

Decongestants SE

A

nervousness/restlessness/palpitations
headache
dry mouth
nasal irritation (depending on route)

increased BP and glucose

REBOUND NASAL CONGESTION IF PROLONGED USE (AVOID USE GREATER THAN 3 DAYS)

72
Q

Intranasal Corticosteroids (Upper Respiratory)

fluticasone (Flonase)

A

ENDS IN -SONE

reduces nasal inflammation and congestion (blocks inflammatory responses) may take 1-4 weeks to reach full effect

beneficial in treating rhinitis; should be used for short term only

73
Q

Intranasal Corticosteroids SE

A

dizziness
hoarseness (vocal cord irritation)
blurred vision
nausea/vomiting
increased nasal secretions

74
Q

Antitussives (Upper Respiratory)

dextromethorphan (Robitussin DM)

A

reduce cough by blocking the cough reflex in medulla (cough control center); SE IS NAUSEA, dizziness and CNS suppression at high doses

used for non productive cough ONLY unless needed to sleep; contraindicated for pts with COPD
short term use only; no alcohol or CNS depressants; get up slowly to avoid falls

opioids may be used for severe cough

75
Q

Upper Respiratory Medications

A

• may need to educated on potential side/adverse effects of OTC meds since pts use w/o supervisor
• combining these drugs may lead to harmful effects due to some meds having similar drug components
• pts should ALWAYS be asked separately about OTC meds

76
Q

Sympathomimetics/Bronchodilators (Lower Respiratory)

Short Acting Beta2-Adrenergic Agonists (SABAs) and Long-Acting Beta2 Agonists (LABAs)

A

-TEROL!!
short acting (albuterol (Ventolin)- RESCUE)
long acting (salmeterol (Severent)) for COPD AND ASTHMA; NOT A RESCUE!!

bronchodilation!!!

ALBUTEROL IS FOR ACUTE ASTHMA ATTACKS; SALMETEROL JS FOR SLOW AND STEADY

how often are they using it? using too much might reverse intended effects or indicate poor asthma control, rebound bronchoconstriction; excessive dosage can cause heart attacks or seizures

77
Q

Sympathomimetics SE

A

increased SNS s/s like pre-workout
increased HR/palpitations/arrhythmias, chest pain
nervousness
tremor
increased energy/anxiety

78
Q

Anticholinergics (Lower Respiratory)

tioptropium (Spiriva)

A

-TROPIUM!!

treatment of bronchospasms; blocks acetylcholine receptors (PNS) reducing frequency of bronchospasms in COPD and asthma

capsule of Dry Powder is used in inhaler
keep capsule in package until ready to use
Long acting: THIS DRUG IS NOT TO BE USED AS RESCUE INHALER!!!

79
Q

Anticholinergics SE

A

blurred vision (contraindicated in narrow angle glaucoma; increases intraocular pressure)
headache
rash
dry mouth
constipation
urinary retention
n/v and indigestion
peripheral edema (aldosterone)
insomnia (increases SNS)
oral ulceration (mucous membrane irritation)

CANT SEE CANT PEE CANT SPIT CANT SHIT

80
Q

Leukotriene Inhibitors (Lower Respiratory)

montelukast (Singulair)

A

-LUKAST!!

decreased acute asthma attacks and exercise induced bronchoconstriction (good for kids depending on lvl of activity); reduces inflammatory processes by decreasing effect of leukotrienes; PREVENTION ONLY!!!

given PO: take tablet 2 hrs before exercise; AVOID USE WITH NSAIDS CAUSE IT BLOCKS DRUG ACTION
NOT TO BE USED AS RESCUE MED!!

81
Q

Leukotriene Inhibitors SE and ADE

A

SE: GI upset, fatigue, neuro disturbances (dizziness/confusion), HA, immunosuppression, angioedema, bleeding

ADE: Steven Johnson’s Syndrome (SJS), suicidal ideation

82
Q

Steroids/Glucocorticoids (Lower Respiratory)

beclomethasone (Beconase)

A

anti-inflammatory (use for moderate-severe exacerbations) may take 1-4 weeks to reach full effect

likely to cause fungal infection if inhaled; consider pt teaching (rinse mouth, spacer use, proper storage)

MUST TAKE DAILY AS PRESCRIBED TO SEE THERAPEUTIC EFFECTS; USE SPACER

83
Q

Steroids/Glucocorticoids SE

A

headache
dry mouth/throat irritation/oral thrush
dysphonia (hoarseness)
adrenal suppression (in high dose long term use only)

84
Q

Lower Respiratory Meds

A

• asthma can be a complicated illness to treat; good pt education is crucial for control (help pt identify triggers of asthma to reduce frequency of attacks)
• consider pt teaching for respirator drug therapy (how to use inhaler and how to store)
• inhaled meds work more quickly than oral, and use of spacers allows for meds to reach target areas for effectively
• increased use of rescue inhaler (albuterol aka Ventolin) can indicate poor control of asthma symptoms; report need of increased use to provide as a step up in drug therapy may be required

85
Q

Chemical Name

A

exact scientific name that describes the chemical structure of a drug

86
Q

generic name (NON PROPRIETARY)

A

official name of the drug, usually simpler than chemical name used by everyone

87
Q

Trade name (PROPRIETARY)

A

brand name that a drug is sold under; chosen by manufacturer

88
Q

Prototype

A

serves as the model drug for the class (STUDY THESE!! ITLL HELP FOR OTHER DRUGS OF THE SAME DRUG CLASS)

89
Q

Therapeutic Classification

A

tells you WHAT the drug does for the body

90
Q

Pharmacologic Classification

A

tells you HOW the drug works in the body (mechanism of action)

91
Q

Oral Meds

A

slowest absorption time

92
Q

IM Absorption

A

rate of absorption depends on blood perfusion level

93
Q

MTC (Minimum Toxic Concentration)

A

smallest amount of drug that can cause harm/SE; dose at which drug starts becoming dangerous

94
Q

Loading Dose

A

high initial dose to achieve quick therapeutic response

95
Q

Rhinitis

A

inflammation and swelling of the mucous membranes in the nose; triggered by release of histamine which causes mucous membranes of the nose and pharynx to swell and increase secretion production

ANTIHISTAMINES AND CORTICOSTEROIDS

96
Q

Sinusitis

A

an infection or inflammation of the lining of the sinuses (air filled pockets that become filled with fluid)

DECONGESTANTS

97
Q

Common Cold

A

viral infection of upper respiratory tract

ANTITUSSIVES

98
Q

Antihistamines Safety and Contraindications

A

avoid drinking and CNS depressants/operating heavy machinery

narrow angle glaucoma (increases intraocular pressure, causing fluid build up)

99
Q

Antihistamines Nursing Care

A

• give oral meds w/food; monitor I and O
• suck on ice chips or sugarless candy to help with dry mouth

100
Q

Decongestants Contraindications

A

HYPERTENSION, coronary artery disease

101
Q

Decongestants Nursing Care

A

MONITOR HR, BP AND BG

be aware of interactions w/caffeine and stimulants, MAOIs and beta blockers

102
Q

Corticosteroids Nursing Care

A

• intranasal preferred to prevent systemic side effects
• inhaled=long term prophylaxis of asthma (taken daily!) NOT FOR ACUTE ATTACK
• IV/Oral= short term therapy of severe, acute asthma (TAPER OFF!!! USE FOR LESS THAN 10 DAYS)
• RINSE MOUTH WITH WATER TO AVOID ORAL THRUSH
• watch for s/s of infection (suppressed immune system) and BG
• KNOW TRIGGERS!

103
Q

The S’s of Steroids (Systemic SE)

A

Soft bones (increase r/f osteoporosis; decreases Ca absorption)
Sight (increase r/f cataracts)
Slimy tongue (thrush-USE SPACER AND RINSE)
Sugar (hyperglycemia)
Sickness (suppresses immune system, increase r/f infection)
Salt (increases aldosterone-fluid/salt retention)

104
Q

SABAs/LABAs Nursing Care

A

• monitor vitals (HR, RR)
• assess breath sounds (wheeze to no wheeze?)
• encourage hydration (thins mucus)
assess # of times SABAs is used
PEAK FLOW METER TO ASSESS ASTHMA CONTROL
use SABA before ICS; WAIT 5 MIN TO ALLOW AIRWAYS TO BE OPEN ENOUGH
• wear medic alert tag and carry rescue inhaler

105
Q

Anticholinergic ADE

A

cardiac dysrhythmias
anaphylaxis
hyperglycemia (cortisol)
depression

106
Q

Anticholinergic Nursing Care

A

• MONITOR VITALS (HR, BP, RR) and I/Os
• encourage hydration to thin mucus (2-3 L)
• keep capsule in package until ready to use
• suck on ice chips or sugarless candy
• rinse mouth to reduce dry mouth and irritation with DPI
• proper technique

107
Q

Leukotriene Inhibitors Nursing Care

A

avoid use of NSAIDs
monitor behavior and signs of worsening depresssion
take once daily at bedtime (if not taken daily, take meds 2 hrs before exercise)